FIELD: medicine, dermatovenerology. SUBSTANCE: the suggested method deals with inspecting a patient, moreover, one should sample patient's venous blood preliminarily to isolate lymphocytes and incubate with solution of monoclonal antibodies to CD54 antigen, detect relative quantity of CD54+ lymphocytes with luminescent microscope and at the value of this parameter being 32% and higher one should predict more severe flow of psoriasis. EFFECT: higher efficiency and accuracy of prediction. 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING SEVERITY DEGREE OF PSORIASIS FLOW | 2000 |
|
RU2187116C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF PSORIASIS | 2011 |
|
RU2461007C1 |
| METHOD FOR EVALUATING THE SEVERITY OF PSORIASIS FLOW | 2003 |
|
RU2242001C1 |
| METHOD OF DIAGNOSIS OF STAPHYLOCOCCUS INFECTION | 1998 |
|
RU2144190C1 |
| METHOD FOR PREDICTING THE TRANSITION OF THE MEDIUM-HEAVY COURSE OF THE NUMMULAR MICROBIAL ECZEMA INTO THE SEVERE COURSE | 2019 |
|
RU2702236C1 |
| METHOD OF PREDICTING THE COURSE OF PSORIASIS | 0 |
|
SU1263250A1 |
| METHOD OF PSORIASIS TREATMENT | 2008 |
|
RU2391978C1 |
| METHOD OF DETECTION OF SENSIBILIZATION TO MEDICINAL ALLERGENS | 1995 |
|
RU2143696C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 PSORIASIS IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2684287C1 |
| METHOD FOR DIAGNOSING SEVERE PSORIASIS IN ADULTS | 2017 |
|
RU2661610C1 |
